Neuraxpharm Denmark ApS
Private limited companyCVR 45449688HerlevActive
Neuraxpharm Denmark ApS is a private limited company, based in Herlev, active in wholesale of pharmaceutical goods and nursing supplies, founded in 2025. The company is new and has been registered for 1 years. The latest net result (2025) was DKK 316k. 8 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesManagement and owners, last 24 months
- New in management: Johan Anders Magnus Wassén (director, 25/02/2025) and Mark Anthony Slater (director, 25/02/2025).
- New owners registered: Neuraxpharm Arzneimittel GmbH (25/02/2025).
Registrations, last 24 months
- 31/07/2026: Moved to Lyskær 3C, 2, 2730 Herlev
- 31/07/2025: Moved to Hørkær 12A, 1, 2730 Herlev
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2025–2025 · amounts in DKK thousand| 2025 | Change | |
|---|---|---|
| Revenue | not stated | – |
| Gross profit | 405 | – |
| Operating profit (EBIT) | 405 | – |
| Profit before tax | 405 | – |
| Net profit | 316 | – |
| Total assets | 776 | – |
| Equity | 356 | – |
| Liabilities | 421 | – |
| Average number of employees | 0 | – |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Annual reports
1 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 25/02/2025 – 31/12/2025 | 05/06/2026 | The company | PDF not statedXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
232 companies in the databaseComparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.
Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 55,982of 69,742 Better than 20% | No. 45,667of 69,964 Better than 35% |
| Same industry and fewer than 20 employees150 companies in the comparison | No. 138of 150 Better than 8% | No. 122of 150 Better than 19% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 12,568of 16,614 Better than 24% | No. 6,831of 16,661 Better than 59% |
| All companies of type ApS66,508 companies in the comparison | No. 53,856of 66,379 Better than 19% | No. 41,598of 66,505 Better than 37% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Wholesale of pharmaceutical goods and nursing supplies- Neuraxpharm Denmark ApSDKK 405k
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Neuraxpharm Denmark ApSDKK 316k
- Ambu A/SDKK 609m
- Stada Nordic ApSDKK 54.6m
- Neuraxpharm Denmark ApSDKK 356k
- Ambu A/SDKK 6bn
- Stada Nordic ApSDKK 346.3m
- Neuraxpharm Denmark ApS4
- Ambu A/S619
- Stada Nordic ApS51
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Neuraxpharm Arzneimittel GmbH100%
Management
2 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Johan Anders Magnus Wassén | Director | 25/02/2025 |
| Mark Anthony Slater | Director | 25/02/2025 |
- Founders
- Neuraxpharm Arzneimittel GmbH
Signing rule: Selskabet tegnes af et medlem af direktionen
Address and production units
1 active production unitsLyskær 3C
2730 Herlev
Herlev Municipality · Postcode 2730
Other companies at the address (8)
- Turner & Townsend ApSOther technical consultancy
- Lindex Denmark ApSRetail sale of clothing
- Duni A/SAgents in furniture, household goods and hardware
- Oatly Denmark ApSWholesale of other food
- Koki Denmark A/SWholesale of machine tools
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Neuraxpharm Denmark ApS | Lyskær 3C, 2, 2730 Herlev | 3 | 1031137760 |
Purpose
Selskabets formål er engrosalg, markedsføre, distribuere og importere farmaceutiske produkter, diætetiske fødevarer og fødevarepræparater.
The purpose is quoted from the register in Danish.
Changes year by year
7 registered events20262 changesaddress 1 · accounts 1
- AddressMoved to Lyskær 3C, 2, 2730 Herlev
- AccountsAnnual report for 2025 published
20255 changesaddress 1 · founded 1 · management 2 · ownership 1
- AddressMoved to Hørkær 12A, 1, 2730 Herlev
- FoundedRegistered as Neuraxpharm Denmark ApS
- ManagementJohan Anders Magnus Wassén appointed director
- ManagementMark Anthony Slater appointed director
- OwnershipNeuraxpharm Arzneimittel GmbH registered as owner (100%)
Related companies
Same industry in Herlev
- Eli Lilly Danmark A/S83 employees
- Stada Nordic ApS51 employees
- Paranova Pack ApS32 employees
- Eidorff Dental ApS11 employees
- Atrivita ApS3 employees
- Tobii Dynavox ApS3 employees
Largest in the industry
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Nomeco A/SDKK 683m
- Orifarm Supply A/SDKK 538.5m
- Novo Nordisk Denmark A/SDKK 497.5m
- Sandoz A/SDKK 260.2m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.